Skip to main navigation
For additional product information, please see

Product Information

  • AviseTest.com

Contact Us

  • Contact Us

Social

Exagen Diagnostics - Logo
  • About Exagen
    • Exagen Quality
    • Lab Certifications
  • Our Products
    • AVISE CTD
      • SLE & Connective Tissue Disease Test
    • AVISE Lupus
      • SLE Diagnostic Test
    • AVISE SLE Monitor
      • SLE Disease Monitoring Test
    • AVISE SLE Prognostic
      • SLE Prognostic Test
    • AVISE APS
      • Antiphospholipid Syndrome Test
    • AVISE MTX
      • Methotrexate Polyglutamate Measuring Test
    • AVISE HCQ
      • The Hydroxychloroquine (HCQ) test measuring drug levels in whole blood
    • AVISE Anti-CarP
      • RA Diagnosis & Prognosis
  • Our People
    • Leadership
    • Board of Directors
    • Careers
  • Our Science
    • CB-CAPs – Lupus Biomarkers
    • Clinical Trials
    • Research & Development
    • Publications
  • Business Development
    • Business Development
    • Partners
  • ESG
    • Corporate Governance
    • ESG Report
  • Investors

    Investor Relations

    • Investor Overview
    • Press Releases
    • Events
    • Presentations
    • Annual Report
    • SEC Filings
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Investor Contacts
    • Email Alerts
Image

SEC Filing Details

SEC Filing Details

Document Details

Form
DEFA14A
Filing Date
May 24, 2023
Document Date
May 24, 2023
Form Description
Additional proxy soliciting materials - definitive
Filing Group
Proxy Filings
Company
Exagen
Issuer
EXAGEN INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
Email Alerts
RSS Feeds
Investor Contacts
© 2024 Exagen Inc. | All Rights Reserved

Footer

  • Terms of Use
  • Notice of Privacy Practices
  • Lab Certifications
  • Contact Us

Social

Image

© 2024 Exagen Inc. | All Rights Reserved

Footer

  • Terms of Use
  • Notice of Privacy Practices
  • Lab Certifications
  • Contact Us

Social

Exagen Quality Seal
  • About Exagen
    • ← Back
    • Exagen Quality
    • Lab Certifications
  • Our Products
    • ← Back
    • AVISE CTD
      • ← Back
      • SLE & Connective Tissue Disease Test
    • AVISE Lupus
      • ← Back
      • SLE Diagnostic Test
    • AVISE SLE Monitor
      • ← Back
      • SLE Disease Monitoring Test
    • AVISE SLE Prognostic
      • ← Back
      • SLE Prognostic Test
    • AVISE APS
      • ← Back
      • Antiphospholipid Syndrome Test
    • AVISE MTX
      • ← Back
      • Methotrexate Polyglutamate Measuring Test
    • AVISE HCQ
      • ← Back
      • The Hydroxychloroquine (HCQ) test measuring drug levels in whole blood
    • AVISE Anti-CarP
      • ← Back
      • RA Diagnosis & Prognosis
    • AVISE PC4d
      • ← Back
      • History of SLE Thrombosis
  • Our People
    • ← Back
    • Leadership
    • Board of Directors
    • Careers
  • Our Science
    • ← Back
    • CB-CAPs – Lupus Biomarkers
    • Clinical Trials
    • Research & Development
    • Publications
  • Business Development
    • ← Back
    • Business Development
    • Partners
  • ESG
    • ← Back
    • Corporate Governance
    • ESG Report
  • Investors

    Investor Relations

    • ← Back
    • Investor Overview
    • Press Releases
    • Events
    • Presentations
    • Annual Report
    • SEC Filings
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Investor Contacts
    • Email Alerts